Experimental cancer drug enters human testing for Tough-to-Treat GI tumors
NCT ID NCT07216560
Summary
This is the first study in US patients testing an experimental drug called 7MW4911 for advanced gastrointestinal cancers that have stopped responding to standard treatments. The research aims to find the safest and most effective dose while checking if the drug helps shrink tumors. The study will enroll about 200 adults with advanced colorectal cancer or other GI cancers who have already tried available treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GI CANCERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fred Hutchinson Cancer Center
NOT_YET_RECRUITINGSeattle, Washington, 98109, United States
Contact Phone: •••-•••-••••
-
Hematology Oncology Associates of the Treasure Coast
RECRUITINGPort Saint Lucie, Florida, 34952, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
START
RECRUITINGLong Island City, New York, 11042, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
START Moutain Region
RECRUITINGWest Valley City, Utah, 84119, United States
Contact Phone: •••-•••-••••
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.